Related references
Note: Only part of the references are listed.An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats
Pierre J. Marie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
The Calcium-sensing Receptor Is Involved in Strontium Ranelate-induced Osteoclast Apoptosis NEW INSIGHTS INTO THE ASSOCIATED SIGNALING PATHWAYS
Anne S. Hurtel-Lemaire et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Prolonged Treatments With Antiresorptive Agents and PTH Have Different Effects on Bone Strength and the Degree of Mineralization in Old Estrogen-Deficient Osteoporotic Rats
Zhiqiang Cheng et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Selective Modification of Bone Quality by PTH, Pamidronate, or Raloxifene
Tara C. Brennan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response
G. J. Atkins et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants
S. D. Bain et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
C. Roux et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis - Results of a five-year, randomized, placebo-controlled trial
Jean-Yves Reginster et al.
ARTHRITIS AND RHEUMATISM (2008)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia
Ego Seeman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Histomorphometric and μCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate
Monique E. Arlot et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate
O. Bruyere et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength
Patrick Ammann et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate
Olivier Bruyere et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation
Naibedya Chattopadhyay et al.
BIOCHEMICAL PHARMACOLOGY (2007)
The correction of BMD measurements for bone strontium content
Glen M. Blake et al.
JOURNAL OF CLINICAL DENSITOMETRY (2007)
Induction of a program gene expression during osteoblast differentiation with strontium ranelate
Ling-Ling Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
A review of strontium ranelate and its effect on DXA scans
Glen M. Blake et al.
JOURNAL OF CLINICAL DENSITOMETRY (2007)
Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older
Ego Seeman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Mechanisms of disease - Bone quality - The material and structural basis of bone strength and fragility
Ego Seeman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors
C Roux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone
D Farlay et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study
JY Reginster et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Drugs used to treat osteoporosis: The critical need for a uniform nomenclature based on their action on bone remodeling
BL Riggs et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells
A Barbara et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
PJ Meunier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats
P Ammann et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
In vitro effects of strontium ranelate on the extracellular calcium-sensing receptor
J Coulombe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium
M Pi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
S 12911-2 inhibits osteoclastic bone resorption in vitro
N Takahashi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation
R Baron et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice
P Delannoy et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
Strontium ranelate: Dose-dependent effects in established postmenopausal vertebral osteoporosis - A 2-year randomized placebo controlled trial
PJ Meunier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Minireview: The OPG/RANKL/RANK system
S Khosla
ENDOCRINOLOGY (2001)
True strength
RS Weinstein
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
SC Manolagas
ENDOCRINE REVIEWS (2000)
Therapeutic approaches to bone diseases
GA Rodan et al.
SCIENCE (2000)
Share Paper
